Education
About Us
Working with TipRanks
Follow Us
Oragenics Inc (OGEN)
:OGEN
OGEN Stock Chart & Stats
$0.91
-$0.04(-10.69%)
At close: 4:00 PM EST
$0.91
-$0.04(-10.69%)
Day’s Range― - ―
52-Week Range$0.82 - $18.87
Previous CloseN/A
Volume445.36K
Average Volume (3M)211.78K
Market Cap
$4.66M
Enterprise Value$4.95M
Total Cash (Recent Filing)$11.40M
Total Debt (Recent Filing)$394.84K
Price to Earnings (P/E)―
Beta2.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.85
Shares Outstanding4,127,173
10 Day Avg. Volume326,842
30 Day Avg. Volume211,777
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)-346.28
Price to Sales (P/S)0.00
P/FCF Ratio-8.53
Enterprise Value/Market Cap1.06
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.71
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Oragenics News
OGEN FAQ
What was Oragenics Inc’s price range in the past 12 months?
Oragenics Inc lowest stock price was $0.82 and its highest was $18.87 in the past 12 months.
What is Oragenics Inc’s market cap?
Oragenics Inc’s market cap is $4.66M.
When is Oragenics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Oragenics Inc’s earnings last quarter?
Currently, no data Available
Is Oragenics Inc overvalued?
According to Wall Street analysts Oragenics Inc’s price is currently Overvalued.
Does Oragenics Inc pay dividends?
Oragenics Inc does not currently pay dividends.
What is Oragenics Inc’s EPS estimate?
Oragenics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oragenics Inc have?
Oragenics Inc has 4,127,173 shares outstanding.
What happened to Oragenics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Oragenics Inc?
Currently, no hedge funds are holding shares in OGEN
Company Description
Oragenics Inc
Oragenics, Inc. (OGEN) is a biopharmaceutical company focused on the development of novel antibiotics and treatments for infectious diseases. The company operates primarily in the biotechnology sector, with a core emphasis on addressing antibiotic resistance and unmet medical needs through its research and development efforts. Oragenics is known for its proprietary lantibiotic platform, which is designed to create new antibiotics with unique mechanisms of action.
Technical Analysis
InMed Pharmaceuticals
―
NLS Pharmaceutics
―
GRI Bio
―
Pasithea Therapeutics Corp
―
Onconetix
―
Ownership Overview
2.68% Insiders
0.06% Mutual Funds
2.90% Other Institutional Investors
94.36% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---